Obsidian Therapeutics
Sheyla Mirabal is currently serving as Principal Scientist in Analytical Development at Obsidian Therapeutics since June 2022, after previously holding the position of Senior Scientist in TIL & Vector Analytical Development at the same company. Prior to joining Obsidian Therapeutics, Sheyla Mirabal worked as a Molecular Biologist at CellBridge LLC.